The National Institute for Food and Drug Surveillance (Invima), an agency that regulates the sector in Colombia, authorized this Wednesday the use of the vaccine China CoronaVac, of the pharmaceutical company Sinovac, in the plan to fight covid-19, according to EFE.
This was announced by the director of Invima, Julio César Aldana, when he intervened in the “Prevention and Action” program in which the Colombian president, Iván Duque, talks about issues related to the coronavirus pandemic. “Today, in record time (…) the Invima authorized the importation of the CoronaVac vaccine from the Sinovac pharmaceutical company, “he said.
The official added that this vaccine joins others already authorized by that body such as those of Pfizer / BioNTech. Likewise, Aldana explained that Invima also approved this week the protocol through which two clinical trials of vaccines are started, one by the German company CureVac and the other by the Australian Clover. “With these they are four clinical trials that run in the country and that allow more than 36,000 Colombians to have access to this biological product, to vaccines, “explained Aldana.
The Colombian government reiterated this Wednesday that vaccination against covid-19 will begin on February 20 with more than 300,000 vaccines that it expects to receive in the middle of the month.
The Minister of Health, Fernando Ruiz, explained at a press conference in which President Duque was also present, that the first doses to be administered by the country are 117,000 of the vaccine developed by Pfizer / BioNtech and about 200,000 from the Chinese laboratory Sinovac.
The Government is also waiting for the World Health Organization (WHO) to authorize the marketing of the vaccine developed by AstraZeneca and the University of Oxford, to begin receiving from that laboratory.
The goal of the Colombian government is to vaccinate 35.2 million people this year, equivalent to 70% of the national population, to achieve herd immunity. To that end, it purchased 61.5 million vaccines from various laboratories, including 20 million that it will receive through the Covax mechanism, which will be enough to vaccinate 10 million people when two doses are necessary.
Bilaterally, the government negotiated another 10 million vaccines with Pfizer (for five million people), and the same amount with AstraZeneca and Moderna, which also require two doses, which will reach five million people.
Another nine million single-dose vaccines were purchased from Janssen, part of Johnson & Johnson, and 2.5 million more from Sinovac, reaching 1.25 million people.
Colombia accumulates 2,125,622 infections and 54,877 deaths due to the coronavirus pandemic.
Eddie is an Australian news reporter with over 9 years in the industry and has published on Forbes and tech crunch.